474 related articles for article (PubMed ID: 19810103)
21. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
22. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms.
Gupta K; Thakur VS; Bhaskaran N; Nawab A; Babcook MA; Jackson MW; Gupta S
PLoS One; 2012; 7(12):e52572. PubMed ID: 23285096
[TBL] [Abstract][Full Text] [Related]
23. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
[TBL] [Abstract][Full Text] [Related]
24. Deacetylation of p53 modulates its effect on cell growth and apoptosis.
Luo J; Su F; Chen D; Shiloh A; Gu W
Nature; 2000 Nov; 408(6810):377-81. PubMed ID: 11099047
[TBL] [Abstract][Full Text] [Related]
25. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes.
Nair SS; Li DQ; Kumar R
Mol Cell; 2013 Feb; 49(4):704-18. PubMed ID: 23352453
[TBL] [Abstract][Full Text] [Related]
26. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation.
Yan C; Wang H; Toh Y; Boyd DD
J Biol Chem; 2003 Jan; 278(4):2309-16. PubMed ID: 12431981
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.
Van Rechem C; Boulay G; Pinte S; Stankovic-Valentin N; Guérardel C; Leprince D
Mol Cell Biol; 2010 Aug; 30(16):4045-59. PubMed ID: 20547755
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
29. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
Chatterjee B; Ghosh K; Kanade SR
Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
[TBL] [Abstract][Full Text] [Related]
31. Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1.
Lee MH; Na H; Kim EJ; Lee HW; Lee MO
Oncogene; 2012 Dec; 31(49):5099-107. PubMed ID: 22286760
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells.
Cecchinato V; Chiaramonte R; Nizzardo M; Cristofaro B; Basile A; Sherbet GV; Comi P
Biochem Pharmacol; 2007 Dec; 74(11):1568-74. PubMed ID: 17868649
[TBL] [Abstract][Full Text] [Related]
34. In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
Kumar A; D'silva M; Dholakia K; Levenson AS
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463302
[TBL] [Abstract][Full Text] [Related]
35. SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.
Scuto A; Kirschbaum M; Buettner R; Kujawski M; Cermak JM; Atadja P; Jove R
Cell Death Dis; 2013 May; 4(5):e635. PubMed ID: 23681230
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models.
Sasaki Y; Negishi H; Idogawa M; Suzuki H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
Mol Cancer Ther; 2008 Apr; 7(4):779-87. PubMed ID: 18413792
[TBL] [Abstract][Full Text] [Related]
37. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Majid S; Igawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):552-60. PubMed ID: 18431742
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]